{"schema_version":"secwatch.filing_event.v1","accession":"0001809519-26-000080","form_type":"8-K","ticker":"GDRX","cik":"0001809519","company_name":"GoodRx Holdings, Inc.","filed_at":"2026-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.959743+00:00","generated_at":"2026-05-15T04:13:23.696653+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"GoodRx appoints Thomas Chan as Chief Accounting Officer effective April 23, 2026","bullets":["Thomas Chan, previously VP Corporate Controller, named Chief Accounting Officer and principal accounting officer.","Annual base salary increased to $310,000 with target bonus of 40% of base salary.","Granted RSU award valued at $131,250 and PSU award valued at $43,750 under 2020 Incentive Award Plan.","Chan joined GoodRx in October 2020 and is a CPA with prior experience at Deloitte & Touche."],"urls":{"canonical":"https://secwatch.observer/filing/0001809519-26-000080","json":"https://secwatch.observer/filing/0001809519-26-000080.json","markdown":"https://secwatch.observer/filing/0001809519-26-000080.md","text":"https://secwatch.observer/filing/0001809519-26-000080.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809519/000180951926000080/0001809519-26-000080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809519/000180951926000080/gdrx-20260423.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T04:13:23.696653+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}